UniProt ID | FOXA1_HUMAN | |
---|---|---|
UniProt AC | P55317 | |
Protein Name | Hepatocyte nuclear factor 3-alpha | |
Gene Name | FOXA1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 472 | |
Subcellular Localization | Nucleus . | |
Protein Description | Transcription factor that is involved in embryonic development, establishment of tissue-specific gene expression and regulation of gene expression in differentiated tissues. Is thought to act as a 'pioneer' factor opening the compacted chromatin for other proteins through interactions with nucleosomal core histones and thereby replacing linker histones at target enhancer and/or promoter sites. Binds DNA with the consensus sequence 5'-[AC]A[AT]T[AG]TT[GT][AG][CT]T[CT]-3' (By similarity). Proposed to play a role in translating the epigenetic signatures into cell type-specific enhancer-driven transcriptional programs. Its differential recruitment to chromatin is dependent on distribution of histone H3 methylated at 'Lys-5' (H3K4me2) in estrogen-regulated genes. Involved in the development of multiple endoderm-derived organ systems such as liver, pancreas, lung and prostate; FOXA1 and FOXA2 seem to have at least in part redundant roles (By similarity). Modulates the transcriptional activity of nuclear hormone receptors. Is involved in ESR1-mediated transcription; required for ESR1 binding to the NKX2-1 promoter in breast cancer cells; binds to the RPRM promoter and is required for the estrogen-induced repression of RPRM. Involved in regulation of apoptosis by inhibiting the expression of BCL2. Involved in cell cycle regulation by activating expression of CDKN1B, alone or in conjunction with BRCA1. Originally described as a transcription activator for a number of liver genes such as AFP, albumin, tyrosine aminotransferase, PEPCK, etc. Interacts with the cis-acting regulatory regions of these genes. Involved in glucose homeostasis.. | |
Protein Sequence | MLGTVKMEGHETSDWNSYYADTQEAYSSVPVSNMNSGLGSMNSMNTYMTMNTMTTSGNMTPASFNMSYANPGLGAGLSPGAVAGMPGGSAGAMNSMTAAGVTAMGTALSPSGMGAMGAQQAASMNGLGPYAAAMNPCMSPMAYAPSNLGRSRAGGGGDAKTFKRSYPHAKPPYSYISLITMAIQQAPSKMLTLSEIYQWIMDLFPYYRQNQQRWQNSIRHSLSFNDCFVKVARSPDKPGKGSYWTLHPDSGNMFENGCYLRRQKRFKCEKQPGAGGGGGSGSGGSGAKGGPESRKDPSGASNPSADSPLHRGVHGKTGQLEGAPAPGPAASPQTLDHSGATATGGASELKTPASSTAPPISSGPGALASVPASHPAHGLAPHESQLHLKGDPHYSFNHPFSINNLMSSSEQQHKLDFKAYEQALQYSPYGSTLPASLPLGSASVTTRSPIEPSALEPAYYQGVYSRPVLNTS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
165 | Phosphorylation | DAKTFKRSYPHAKPP CHHHCHHHCCCCCCC | 43.54 | 19835603 | |
166 | Phosphorylation | AKTFKRSYPHAKPPY HHHCHHHCCCCCCCC | 11.76 | 19835603 | |
223 | Phosphorylation | NSIRHSLSFNDCFVK HHHHHHCHHCCEEEE | 25.64 | 23312004 | |
234 | Phosphorylation | CFVKVARSPDKPGKG EEEEEECCCCCCCCC | 27.93 | 25849741 | |
237 | Acetylation | KVARSPDKPGKGSYW EEECCCCCCCCCCCE | 60.08 | 22528795 | |
240 | Acetylation | RSPDKPGKGSYWTLH CCCCCCCCCCCEEEC | 53.89 | 22528783 | |
259 | Phosphorylation | NMFENGCYLRRQKRF CCCCCCEEEEECCCC | 12.49 | - | |
264 | Acetylation | GCYLRRQKRFKCEKQ CEEEEECCCCCCCCC | 58.97 | 22528771 | |
267 | Acetylation | LRRQKRFKCEKQPGA EEECCCCCCCCCCCC | 45.58 | 22528789 | |
270 | Acetylation | QKRFKCEKQPGAGGG CCCCCCCCCCCCCCC | 71.86 | 22528777 | |
280 | Phosphorylation | GAGGGGGSGSGGSGA CCCCCCCCCCCCCCC | 32.82 | 22210691 | |
282 | Phosphorylation | GGGGGSGSGGSGAKG CCCCCCCCCCCCCCC | 41.50 | 20068231 | |
285 | Phosphorylation | GGSGSGGSGAKGGPE CCCCCCCCCCCCCCH | 38.82 | 20068231 | |
288 | Acetylation | GSGGSGAKGGPESRK CCCCCCCCCCCHHCC | 68.85 | 26051181 | |
293 | Phosphorylation | GAKGGPESRKDPSGA CCCCCCHHCCCCCCC | 48.00 | 20068231 | |
298 | Phosphorylation | PESRKDPSGASNPSA CHHCCCCCCCCCCCC | 58.06 | 23927012 | |
301 | Phosphorylation | RKDPSGASNPSADSP CCCCCCCCCCCCCCC | 53.45 | 25159151 | |
304 | Phosphorylation | PSGASNPSADSPLHR CCCCCCCCCCCCCCC | 49.29 | 23927012 | |
307 | Phosphorylation | ASNPSADSPLHRGVH CCCCCCCCCCCCCCC | 29.13 | 30278072 | |
316 | Acetylation | LHRGVHGKTGQLEGA CCCCCCCCCCCCCCC | 34.31 | 26051181 | |
317 | Phosphorylation | HRGVHGKTGQLEGAP CCCCCCCCCCCCCCC | 34.45 | 20639409 | |
331 | Phosphorylation | PAPGPAASPQTLDHS CCCCCCCCCCCCCCC | 21.46 | 25159151 | |
334 | Phosphorylation | GPAASPQTLDHSGAT CCCCCCCCCCCCCCC | 37.22 | 30278072 | |
338 | Phosphorylation | SPQTLDHSGATATGG CCCCCCCCCCCCCCC | 29.77 | 30278072 | |
341 | Phosphorylation | TLDHSGATATGGASE CCCCCCCCCCCCCHH | 28.42 | 30278072 | |
343 | Phosphorylation | DHSGATATGGASELK CCCCCCCCCCCHHCC | 31.62 | 30278072 | |
347 | Phosphorylation | ATATGGASELKTPAS CCCCCCCHHCCCCCC | 46.89 | 30278072 | |
351 | Phosphorylation | GGASELKTPASSTAP CCCHHCCCCCCCCCC | 36.39 | 25849741 | |
355 | Phosphorylation | ELKTPASSTAPPISS HCCCCCCCCCCCCCC | 30.60 | 25627689 | |
395 | Phosphorylation | LKGDPHYSFNHPFSI CCCCCCCCCCCCCCH | 19.28 | 28348404 | |
427 | Phosphorylation | YEQALQYSPYGSTLP HHHHHHHCCCCCCCC | 9.93 | 29496963 | |
429 | Phosphorylation | QALQYSPYGSTLPAS HHHHHCCCCCCCCCC | 20.12 | - | |
448 | Phosphorylation | SASVTTRSPIEPSAL CCEEECCCCCCHHHC | 28.30 | 25849741 | |
453 | Phosphorylation | TRSPIEPSALEPAYY CCCCCCHHHCCCHHH | 32.47 | 25841592 | |
459 | Phosphorylation | PSALEPAYYQGVYSR HHHCCCHHHCCCCCC | 13.67 | 28102081 | |
460 | Phosphorylation | SALEPAYYQGVYSRP HHCCCHHHCCCCCCC | 10.82 | 28102081 | |
464 | Phosphorylation | PAYYQGVYSRPVLNT CHHHCCCCCCCCCCC | 13.04 | 28102081 | |
465 | Phosphorylation | AYYQGVYSRPVLNTS HHHCCCCCCCCCCCC | 27.92 | 28102081 | |
471 | Phosphorylation | YSRPVLNTS------ CCCCCCCCC------ | 31.49 | 24719451 | |
472 | Phosphorylation | SRPVLNTS------- CCCCCCCC------- | 36.83 | 28348404 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FOXA1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FOXA1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...